4.5 Article

The pathogenic c.1171A>G (p.Arg391Gly) and c.2359G>A (p.Val787Ile) ABCC6 variants display incomplete penetrance causing pseudoxanthoma elasticum in a subset of individuals

Journal

HUMAN MUTATION
Volume 43, Issue 12, Pages 1872-1881

Publisher

WILEY-HINDAWI
DOI: 10.1002/humu.24498

Keywords

calcification; genetic diagnosis; incomplete penetrance; pseudoxanthoma elasticum; pyrophosphate; rare disease

Funding

  1. Ministry for Innovation and Technology from the source of the NKFIH [UNKP-22-5-SE-2, UNKP-21-5-SE-15]
  2. Hungarian Academy of Sciences (MTA-SE Lendulet) [LP2015-11/2015]
  3. NIH NIAMS [R01AR072695]
  4. PXE International
  5. Research Foundation Flanders (FWO) [G061521N]
  6. Universiteit Gent [BOF08/01M01108]
  7. Hungarian Academy of Sciences (Bolyai Janos Fellowship, Mobility grant) [BO/00730/19/8]
  8. European Cooperation in Science and Technology [CA16-115]
  9. PXE Italia Odv
  10. U.S Department of State (Fulbright Visiting Scholar Program)
  11. National Research, Development and Innovation Office (NKFIH OTKA, Thematic Excellence Programme) [FK131946, K132695, K135798, KH125566, TKP2020-NKA-06]

Ask authors/readers for more resources

Incomplete penetrance is a source of heterogeneity in pseudoxanthoma elasticum. Two incomplete penetrant pathogenic variants were identified, but they are only deleterious when a yet unknown interacting partner of ABCC6 is mutated simultaneously.
ABCC6 promotes ATP efflux from hepatocytes to bloodstream. ATP is metabolized to pyrophosphate, an inhibitor of ectopic calcification. Pathogenic variants of ABCC6 cause pseudoxanthoma elasticum, a highly variable recessive ectopic calcification disorder. Incomplete penetrance may initiate disease heterogeneity, hence symptoms may not, or differently manifest in carriers. Here, we investigated whether incomplete penetrance is a source of heterogeneity in pseudoxanthoma elasticum. By integrating clinical and genetic data of 589 patients, we created the largest European cohort. Based on allele frequency alterations, we identified two incomplete penetrant pathogenic variants, c.2359G>A (p.Val787Ile) and c.1171A>G (p.Arg391Gly), with 6.5% and 2% penetrance, respectively. However, when penetrant, the c.1171A>G (p.Arg391Gly) manifested a clinically unaltered severity. After applying in silico and in vitro characterization, we suggest that incomplete penetrant variants are only deleterious if a yet unknown interacting partner of ABCC6 is mutated simultaneously. The low penetrance of these variants should be contemplated in genetic counseling.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available